Conmed (NYSE: CNMD) reported Q4 EPS of $0.42, $0.48 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $250.9 million versus the consensus estimate of $302.51 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.